Super Strength Myo-Leptin CLA 1500 mg 90’s

AED 168.00 AED 126.00


CLA Myoleptin 1500 is an advanced CLA supplement designed for elite athletes, bodybuilders and anyone striving to get into peak condition. Use CLA Myoleptin™ 1500 with your intensive training program to support your body-shaping goals. CLA is believed to work by modulating oxidative enzyme activity as well as energy metabolism. Derived from all natural safflower oil and contains no natural or artificial stimulants of any kind. Perfectfor people sensitive to the effects of caffeine and other thermogenic.

Directions: Take two tablets with the 1st meal and take additional 1 tablet with the 2nd meal.

Warning: Not intended for use by pregnant or nursing women. If you are taking any medications or have any medical condition, consult your doctor before use.

حمض اللينوليك مكمل طبيعي للتحكم بالوزن يساعد على اعاده تشكيل قوام الجسم عن طريق تقليل الدهون وبناء كتله العضلة يوجد CLA في الغذاء ولكن الغذاء وحده لن يقدم كمية CLA كافية لتحقيق الفوائد الصحية. للوصول إلى الجرعة المثلى من CLA (3000) ملغ فإنه يجب على الشخص أن يضيف إلى نظامه الغذائي كبسولات من شركة

استشارة الطبيب أو الصيدلي في حالة الحمل أو عند استخدام أي مستحضر طبي آخر.

الجرعة : للبالغين :تناول 2 حبة مع الوجبة الاولى وحبة واحدة مع الوجبة الثانية يوميا .

Supplement Facts

Serving Size 2 Softgels
Servings Per Container 45
Amount Per Serving % Daily Value
Calories 30
Calories from Fat 25
Total Fat 3 g 5%**
Protein <1 g 1%**
Myoleptin™ CLA 3,000 mg (3 g) ***
  (from Safflower Oil)
Contains 78-84 percent Conjugated Linoleic Acid(CLA) 2,340 mg – 2,520 mg
**Percent Daily Values are based on a 2,000 calorie diet.
***Daily Value not established.

Other Ingredients: Gelatin, Vegetable Glycerin, Natural Caramel Color.

No Artificial Flavor or Sweetener, No Preservatives, No Sugar, No Starch, No Milk, No Lactose,&amp;nbsp; No Soy, No Gluten, No Wheat, No Yeast, No Fish. Sodium Free

There are no reviews yet.

Be the first to review “Super Strength Myo-Leptin CLA 1500 mg 90’s”

Your email address will not be published. Required fields are marked *